The White House is pushing to get Paxlovid, a drug which reduces the risk of COVID hospitalization by 90%, into the hands of more Americans. The drug's rollout has been slow, failing to reach many Americans eligible for treatment.
President Biden is seen delivering remarks on COVID-19 on March 30. On Tuesday, the White House will announce a new push to get more doses of the COVID antiviral medication Paxlovid to more Americans.
The rollout of the medication has been slow since it was authorized for use in December, failing to reach many Americans eligible for treatment. Many pharmacies have not yet been able to stock the drug and some physicians have been hesitant to prescribe it over concerns about depleting the supply — which the White House now describes as “ample.”
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Consulte Mais informação »
White House pushes to increase use of Pfizer’s Covid treatment PaxlovidAdministration officials say the drug has been underused in the fight against the pandemic.
Consulte Mais informação »
More than 100 million Americans have received 1st COVID booster shot since August
Consulte Mais informação »
Americans who haven't had COVID-19 are now in the minority following omicron surge
Consulte Mais informação »
White House announces expanded access to antiviral pills for COVIDThe U.S. has ordered enough supply of the pills for 20 million people.
Consulte Mais informação »
Harris positive for COVID-19, Biden not ‘close contact’The White House said Tuesday that Harris tested positive on both rapid and a PCR tests, and said she “has exhibited no symptoms.” Harris will isolate at her residence but continue to work remotely.
Consulte Mais informação »